Drug company Novartis has named Klaus Moosmayer as chief ethics, risk and compliance officer, effective Dec. 1. Moosmayer will report to the CEO of Novartis in Basel, Switzerland, and serve as a member of the company’s executive committee.

His post was added to the committee in April in an effort to help the company restore its reputation, which took a hit over a recently revealed connection with President Donald Trump’s former personal lawyer.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]